239 related articles for article (PubMed ID: 15788130)
21. Cladonia furcata polysaccharide induced apoptosis in human leukemia K562 cells.
Lin X; Cai YJ; Li ZX; Liu ZL; Yin SF; Zhao JC
Acta Pharmacol Sin; 2001 Aug; 22(8):716-20. PubMed ID: 11749844
[TBL] [Abstract][Full Text] [Related]
22. Phase I/II study of subcutaneous homoharringtonine in patients with chronic myeloid leukemia who have failed prior therapy.
Quintás-Cardama A; Kantarjian H; Garcia-Manero G; O'Brien S; Faderl S; Estrov Z; Giles F; Murgo A; Ladie N; Verstovsek S; Cortes J
Cancer; 2007 Jan; 109(2):248-55. PubMed ID: 17154172
[TBL] [Abstract][Full Text] [Related]
23. [Effect of specific siRNA targeting against bcr-abl chimeric gene on chronic myelogenous leukemia cells].
Wang S; Chai YB; Liu F; Zhang XY; Jia W; Xie X; Yu WQ; Shang ZC; Jin BQ; Sun BZ
Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(3):198-202. PubMed ID: 15854468
[TBL] [Abstract][Full Text] [Related]
24. [Vascular endothelial growth factor antisense oligodeoxynucleotide enhance drug-sensitivity of myeloid leukemia cells to homoharringtonine].
Fei J; Zhang H
Zhonghua Xue Ye Xue Za Zhi; 2005 Jan; 26(1):27-30. PubMed ID: 15946505
[TBL] [Abstract][Full Text] [Related]
25. Prolonged chronic phase in chronic myelogenous leukemia after homoharringtonine therapy.
Li YF; Deng ZK; Xuan HB; Zhu JB; Ding BH; Liu XN; Chen BA
Chin Med J (Engl); 2009 Jun; 122(12):1413-7. PubMed ID: 19567163
[TBL] [Abstract][Full Text] [Related]
26. A novel kind of nitrogen heterocycle compound induces apoptosis of human chronic myelogenous leukemia K562 cells.
Ding G; Liu F; Yang T; Jiang Y; Fu H; Zhao Y
Bioorg Med Chem; 2006 Jun; 14(11):3766-74. PubMed ID: 16466924
[TBL] [Abstract][Full Text] [Related]
27. Indian black scorpion (Heterometrus bengalensis Koch) venom induced antiproliferative and apoptogenic activity against human leukemic cell lines U937 and K562.
Das Gupta S; Debnath A; Saha A; Giri B; Tripathi G; Vedasiromoni JR; Gomes A; Gomes A
Leuk Res; 2007 Jun; 31(6):817-25. PubMed ID: 16876244
[TBL] [Abstract][Full Text] [Related]
28. Correlation between survivin mRNA expression and homoharringtonine induced apoptosis of malignant hematopoietic cells.
Cai Z; Bao HY; Lin MF
Chin Med J (Engl); 2005 Apr; 118(7):548-54. PubMed ID: 15820085
[TBL] [Abstract][Full Text] [Related]
29. Actinomycin D inhibiting K562 cell apoptosis elicited by salvicine but not decreasing its cytotoxicity.
Qing C; Miao ZH; Tong LJ; Zhang JS; Ding J
Acta Pharmacol Sin; 2003 May; 24(5):415-21. PubMed ID: 12740176
[TBL] [Abstract][Full Text] [Related]
30. Gene expression pattern in apoptotic QGY-7703 cells induced by homoharringtonine.
Jin W; Qu LF; Chen Q; Chang XZ; Wu J; Shao ZM
Acta Pharmacol Sin; 2007 Jun; 28(6):859-68. PubMed ID: 17506945
[TBL] [Abstract][Full Text] [Related]
31. [Effect of Autophagy on Homoharringtonine-treated K562 Cells].
Lu XY; Ye LL; Shi YY; Ding YH; Li YF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Apr; 25(2):412-417. PubMed ID: 28446285
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of phosphotyrosine phosphatase 1B causes resistance in BCR-ABL-positive leukemia cells to the ABL kinase inhibitor STI571.
Koyama N; Koschmieder S; Tyagi S; Portero-Robles I; Chromic J; Myloch S; Nürnberger H; Rossmanith T; Hofmann WK; Hoelzer D; Ottmann OG
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2025-31. PubMed ID: 16609011
[TBL] [Abstract][Full Text] [Related]
33. Gleditsia sinensis fruit extract is a potential chemotherapeutic agent in chronic and acute myelogenous leukemia.
Chow LM; Chui CH; Tang JC; Teo IT; Lau FY; Cheng GY; Wong RS; Leung TW; Lai KB; Yau MY; Gou D; Chan AS
Oncol Rep; 2003; 10(5):1601-7. PubMed ID: 12883747
[TBL] [Abstract][Full Text] [Related]
34. [Induction of apoptosis by harringtonine and homoharringtonine in HL-60 cells].
Li L; Xia LJ; Jiang C; Han R
Yao Xue Xue Bao; 1994; 29(9):667-72. PubMed ID: 7900538
[TBL] [Abstract][Full Text] [Related]
35. alpha-Anordrin-induced apoptosis of leukemia K562 cells is not prevented by cicloheximide.
Lou LG; Xu B
Zhongguo Yao Li Xue Bao; 1997 Mar; 18(2):169-72. PubMed ID: 10072974
[TBL] [Abstract][Full Text] [Related]
36. ABT-737 is a useful component of combinatory chemotherapies for chronic myeloid leukaemias with diverse drug-resistance mechanisms.
Kuroda J; Kimura S; Andreeff M; Ashihara E; Kamitsuji Y; Yokota A; Kawata E; Takeuchi M; Tanaka R; Murotani Y; Matsumoto Y; Tanaka H; Strasser A; Taniwaki M; Maekawa T
Br J Haematol; 2008 Jan; 140(2):181-90. PubMed ID: 18028486
[TBL] [Abstract][Full Text] [Related]
37. [Retardation of human drug-resistant HL-60 cell in G1 phase and induction of sensitive cell to apoptosis by cyclosporine A].
He QY; Zhang HQ; Pang DB; Chi XS; Xue SB
Yao Xue Xue Bao; 1996; 31(10):721-6. PubMed ID: 9863237
[TBL] [Abstract][Full Text] [Related]
38. The actinomycin D-induced apoptosis in BCR-ABL-positive K562 cells is associated with cytoplasmic translocation and cleavage of RNA helicase A.
Abdelhaleem M
Anticancer Res; 2003; 23(1A):485-90. PubMed ID: 12680254
[TBL] [Abstract][Full Text] [Related]
39. Dup-697, a specific COX-2 inhibitor, suppresses growth and induces apoptosis on K562 leukemia cells by cell-cycle arrest and caspase-8 activation.
Peng HL; Zhang GS; Liu JH; Gong FJ; Li RJ
Ann Hematol; 2008 Feb; 87(2):121-9. PubMed ID: 17999062
[TBL] [Abstract][Full Text] [Related]
40. Downregulation of Bcr-Abl in K562 cells restores susceptibility to apoptosis: characterization of the apoptotic death.
McGahon AJ; Brown DG; Martin SJ; Amarante-Mendes GP; Cotter TG; Cohen GM; Green DR
Cell Death Differ; 1997 Feb; 4(2):95-104. PubMed ID: 16465215
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
